The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
infographic
Understanding the Stakes of IND Submissions: Why Timely Approvals Matter
Read More
post
291 FDA Complete Response Letters Decoded: Insights for Biologics CMC Strategy
Read More
post
Oral Drug Product Development of Small Molecules
Read More
webinar
Ask Me Anything Series – CMC and Regulatory Alignment: Lessons from the Front Lines
Read More
Let's move from science to success.
Let’s Talk